首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Influence of Inoculum Size and Marbofloxacin Plasma Exposure on the Amplification of Resistant Subpopulations of Klebsiella pneumoniae in a Rat Lung Infection Model
【2h】

Influence of Inoculum Size and Marbofloxacin Plasma Exposure on the Amplification of Resistant Subpopulations of Klebsiella pneumoniae in a Rat Lung Infection Model

机译:接种量和马尔波沙星血浆暴露量对大鼠肺部感染模型中肺炎克雷伯菌耐药亚群扩增的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We tested the hypothesis that the bacterial load at the infection site could impact considerably on the pharmacokinetic/pharmacodynamic (PK/PD) parameters of fluoroquinolones. Using a rat lung infection model, we measured the influence of different marbofloxacin dosage regimens on selection of resistant bacteria after infection with a low (105 CFU) or a high (109 CFU) inoculum of Klebsiella pneumoniae. For daily fractionated doses of marbofloxacin, prevention of resistance occurred for an area-under-the-concentration-time-curve (AUC)/MIC ratio of 189 h for the low inoculum, whereas for the high inoculum, resistant-subpopulation enrichment occurred for AUC/MIC ratios up to 756 h. For the high-inoculum-infected rats, the AUC/MIC ratio, Cmax/MIC ratio, and time within the mutant selection window (TMSW) were not found to be effective predictors of resistance prevention upon comparison of fractionated and single administrations. An index corresponding to the ratio of the time that the drug concentrations were above the mutant prevention concentration (MPC) over the time that the drug concentrations were within the MSW (T>MPC/TMSW) was the best predictor of the emergence of resistance: a T>MPC/TMSW ratio of 0.54 was associated with prevention of resistance for both fractionated and single administrations. These results suggest that the enrichment of resistant bacteria depends heavily on the inoculum size at the start of an antimicrobial treatment and that classical PK/PD parameters cannot adequately describe the impact of different dosage regimens on enrichment of resistant bacteria. We propose an original index, the T>MPC/TMSW ratio, which reflects the ratio of the time that the less susceptible bacterial subpopulation is killed over the time that it is selected, as a potentially powerful indicator of prevention of enrichment of resistant bacteria. This ratio is valid only if plasma concentrations achieve the MPC.
机译:我们检验了以下假设,即感染部位的细菌载量可能会严重影响氟喹诺酮类药物的药代动力学/药效学(PK / PD)参数。使用大鼠肺部感染模型,我们测量了低(10 5 CFU)或高(10 9 CFU)肺炎克雷伯菌的接种物。对于每日分次剂量的马西沙星,低接种量的浓度-时间-曲线下面积(AUC)/ MIC比为189 h可以防止耐药性,而高接种量的情况下,耐药菌亚群的富集发生了AUC / MIC比高达756小时。对于高接种量感染的大鼠,在比较分次给药和单次给药时,发现AUC / MIC比,Cmax / MIC比和突变选择窗(TMSW)内的时间不是预防耐药的有效预测指标。对应于药物浓度高于突变预防浓度(MPC)的时间与药物浓度在MSW范围内的时间之比(T> MPC / TMSW)的指数是耐药性出现的最佳预测指标: T> MPC / TMSW比为0.54与分次和单次给药的抗药性相关。这些结果表明,耐药菌的富集在很大程度上取决于抗菌剂治疗开始时的接种量,并且经典的PK / PD参数不能充分描述不同剂量方案对耐药菌富集的影响。我们提出了一个原始指标,即T> MPC / TMSW比率,该比率反映了较不敏感的细菌亚群在被选择的时间内被杀死的时间的比率,作为预防耐药菌富集的潜在有力指标。仅当血浆浓度达到MPC时,此比率才有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号